TENT4A Non-Canonical Poly(A) Polymerase Regulates DNA-Damage Tolerance via Multiple Pathways That Are Mutated in Endometrial Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Jun 2021
Historique:
received: 25 04 2021
revised: 20 06 2021
accepted: 21 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 8 2021
Statut: epublish

Résumé

TENT4A (PAPD7) is a non-canonical poly(A) polymerase, of which little is known. Here, we show that TENT4A regulates multiple biological pathways and focuses on its multilayer regulation of translesion DNA synthesis (TLS), in which error-prone DNA polymerases bypass unrepaired DNA lesions. We show that TENT4A regulates mRNA stability and/or translation of DNA polymerase η and RAD18 E3 ligase, which guides the polymerase to replication stalling sites and monoubiquitinates PCNA, thereby enabling recruitment of error-prone DNA polymerases to damaged DNA sites. Remarkably, in addition to the effect on RAD18 mRNA stability via controlling its poly(A) tail, TENT4A indirectly regulates RAD18 via the tumor suppressor CYLD and via the long non-coding antisense RNA

Identifiants

pubmed: 34203408
pii: ijms22136957
doi: 10.3390/ijms22136957
pmc: PMC8267958
pii:
doi:

Substances chimiques

Chromosomal Proteins, Non-Histone 0
DNA-Binding Proteins 0
PAXIP1 protein, human 0
RAD18 protein, human 0
RNA, Messenger 0
Ubiquitin-Protein Ligases EC 2.3.2.27
Polynucleotide Adenylyltransferase EC 2.7.7.19
DNA-Directed DNA Polymerase EC 2.7.7.7
TENT4A protein, human EC 2.7.7.7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Israel Science Foundation
ID : 684/12
Organisme : Minerva Foundation
ID : 120855
Organisme : Flight Attendant Medical Research Institute
ID : 032001

Références

EMBO J. 2004 Oct 1;23(19):3886-96
pubmed: 15359278
Mol Cell Biol. 2005 Nov;25(22):10183-9
pubmed: 16260630
Biochem Biophys Res Commun. 2013 Mar 1;432(1):135-40
pubmed: 23376078
Nucleic Acids Res. 2018 May 18;46(9):4560-4574
pubmed: 29590477
Genes Dev. 2004 Jan 1;18(1):1-11
pubmed: 14724175
Nucleic Acids Res. 2015 Feb 18;43(3):1637-45
pubmed: 25589543
PLoS Genet. 2011 Sep;7(9):e1002262
pubmed: 21931560
Mol Cell. 2006 May 5;22(3):407-13
pubmed: 16678112
Nat Commun. 2017 Oct 16;8(1):859
pubmed: 29038466
Cell Cycle. 2006 Sep;5(17):1918-22
pubmed: 16969082
Nat Rev Mol Cell Biol. 2014 Jul;15(7):465-81
pubmed: 24954209
Cancer Res. 2006 Jan 1;66(1):134-42
pubmed: 16397225
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
DNA Repair (Amst). 2015 Aug;32:172-179
pubmed: 26002197
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
Genome Res. 2018 Nov;28(11):1747-1756
pubmed: 30341162
DNA Repair (Amst). 2008 May 3;7(5):775-87
pubmed: 18353733
Science. 2018 Aug 17;361(6403):701-704
pubmed: 30026317
Mol Cancer Ther. 2016 Jul;15(7):1669-81
pubmed: 27196765
Nat Rev Mol Cell Biol. 2012 Feb 23;13(3):141-52
pubmed: 22358330
Nat Rev Mol Cell Biol. 2005 Dec;6(12):943-53
pubmed: 16341080
Chem Res Toxicol. 2017 Nov 20;30(11):1942-1955
pubmed: 28841374
Science. 1994 Dec 23;266(5193):1959-60
pubmed: 7801122
Genes Dev. 2014 Dec 15;28(24):2693-8
pubmed: 25512557
Methods Mol Biol. 2012;920:529-42
pubmed: 22941626
Nat Commun. 2014 Nov 25;5:5437
pubmed: 25421715
Hepatology. 2019 Apr;69(4):1398-1411
pubmed: 30365161
Nature. 2002 Sep 12;419(6903):135-41
pubmed: 12226657
RNA. 2012 Jun;18(6):1289-95
pubmed: 22543866
Nat Rev Mol Cell Biol. 2010 Mar;11(3):208-19
pubmed: 20177396
DNA Repair (Amst). 2016 Aug;44:59-67
pubmed: 27262613
Nucleic Acids Res. 2013 Mar 1;41(5):3079-93
pubmed: 23345618
Science. 2000 Aug 4;289(5480):774-9
pubmed: 10926539
Nature. 2012 Nov 15;491(7424):454-7
pubmed: 23064229
Nat Protoc. 2006;1(1):302-7
pubmed: 17406249
Nucleic Acids Res. 2012 Jan;40(1):170-80
pubmed: 21908406
DNA Repair (Amst). 2008 Oct 1;7(10):1636-46
pubmed: 18634905
Immunity. 2012 Dec 14;37(6):971-85
pubmed: 23159437
Crit Rev Biochem Mol Biol. 2019 Jun;54(3):301-332
pubmed: 31429594
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E3978-E3986
pubmed: 29632194
EMBO J. 2009 Feb 18;28(4):383-93
pubmed: 19153606
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Dev Biol. 2013 Jan 1;373(1):64-71
pubmed: 23063797
Mol Cell. 2004 May 21;14(4):491-500
pubmed: 15149598
Mol Cell. 2010 Jan 15;37(1):143-9
pubmed: 20129063
Trends Immunol. 2006 Jul;27(7):313-21
pubmed: 16737852
Nature. 2013 May 2;497(7447):67-73
pubmed: 23636398
Front Pharmacol. 2016 Nov 01;7:409
pubmed: 27847479

Auteurs

Umakanta Swain (U)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.

Gilgi Friedlander (G)

The Mantoux Bioinformatics Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot 7610001, Israel.

Urmila Sehrawat (U)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.

Avital Sarusi-Portuguez (A)

The Mantoux Bioinformatics Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot 7610001, Israel.

Ron Rotkopf (R)

Bioinformatics Unit, Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel.

Charlotte Ebert (C)

Center for Integrated Protein Science at the Department of Chemistry, Ludwig-Maximilians-Universität München, Butenandtstrasse 5-13, 81377 München, Germany.

Tamar Paz-Elizur (T)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.

Rivka Dikstein (R)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.

Thomas Carell (T)

Center for Integrated Protein Science at the Department of Chemistry, Ludwig-Maximilians-Universität München, Butenandtstrasse 5-13, 81377 München, Germany.

Nicholas E Geacintov (NE)

Chemistry Department, New York University, New York, NY 10003, USA.

Zvi Livneh (Z)

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH